Hoag Hospital in Newport Beach is starting a research study to identify and characterize potential early disease markers for cancer diagnostics, cancer progression and treatment resistance, according to a news release.
In partnership with Exosome Sciences, a subsidiary of Aethlon Medical Inc., scientists will study nanoparticles called exosomes in cancer patients and individuals at high genetic risk for cancer.
Visit Daily Pilot to view the original article.
